Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07776314 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Are There Any Clinical Benefits to Screening for Late -Onset Gestational Diabetes Mellitus?"

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 20, 2026 (before its estimated September 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study aims to screen women who have a negative Gestational diabetes mellitus (GDM) result in routine screening tests or who have never had it with the Fasting Blood Glucose Test (FBG) at 32-34 weeks of gestation to diagnose late-onset GDM with routine FBG ≥5.1 mmol/L (92mg/dl) in fasting blood, and to investigate its connection with perinatal and maternal outcomes, hoping to inform about late-stage GDM.
Trial Details
NCT Number NCT07776314
Lead Sponsor Izmir Ataturk Training and Research Hospital
Conditions
(from sponsor)		 Pregnancy in Diabetes, Pregnancy, Pregnancy Outcomes
Related terms Diabetes, Gestational, Pregnancy in Diabetics
Enrollment 128 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov